Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-049117)

Filing Details

Accession Number:: 0001209191-19-049117
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-11 12:35:25
Reporting Period:: 2019-09-11

Accepted Time:: 2019-09-11 12:35:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1515673	Ultragenyx Pharmaceutical Inc.	RARE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1248093	D Emil Kakkis	C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-11	5,000	$43.63	472,479	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,559,741	Indirect	By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009